MedTrace Logo

c9,t11-CLA in Children and Adolescents With Allergic Asthma

NCT01026506 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2009-12-04

No results posted yet for this study

Summary

The study was performed to investigate the effects of a dietary intervention with c9,t11-CLA on clinical and immunological parameters in children and adolescents with allergic bronchial asthma.

Conditions

  • Allergic Bronchial Asthma

Interventions

DIETARY_SUPPLEMENT

conjugated linoleic acid

3 g/d of an esterified CLA preparation free of t10,c12-CLA (75% c9,t11-CLA, 87% purity) or placebo oil mixed in yoghurt for 12 weeks

Sponsors & Collaborators

  • Cognis Deutschland GmbH & Co. KG

    collaborator INDUSTRY

  • University of Jena

    lead OTHER

Principal Investigators

  • Gerhard Jahreis, Prof. Dr. · University of Jena, Dept. of Nutritional Physiology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2008-12-31
Completion
2008-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01026506 on ClinicalTrials.gov